152 related articles for article (PubMed ID: 30449026)
21. Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease.
Deenonpoe R; Mairiang E; Mairiang P; Pairojkul C; Chamgramol Y; Rinaldi G; Loukas A; Brindley PJ; Sripa B
Sci Rep; 2017 Feb; 7():42744. PubMed ID: 28198451
[TBL] [Abstract][Full Text] [Related]
22. Proteomic identification of plasma protein tyrosine phosphatase alpha and fibronectin associated with liver fluke, Opisthorchis viverrini, infection.
Khoontawad J; Laothong U; Roytrakul S; Pinlaor P; Mulvenna J; Wongkham C; Yongvanit P; Pairojkul C; Mairiang E; Sithithaworn P; Pinlaor S
PLoS One; 2012; 7(9):e45460. PubMed ID: 23029023
[TBL] [Abstract][Full Text] [Related]
23. Cytokine profiles in Opisthorchis viverrini stimulated peripheral blood mononuclear cells from cholangiocarcinoma patients.
Surapaitoon A; Suttiprapa S; Khuntikeo N; Pairojkul C; Sripa B
Parasitol Int; 2017 Feb; 66(1):889-892. PubMed ID: 27769807
[TBL] [Abstract][Full Text] [Related]
24. Ultrasonographic features of hepatobiliary pathology in opisthorchiasis and opisthorchiasis-associated cholangiocarcinoma.
Mairiang E
Parasitol Int; 2017 Aug; 66(4):378-382. PubMed ID: 27956092
[TBL] [Abstract][Full Text] [Related]
25. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis.
Techasen A; Loilome W; Namwat N; Duenngai K; Cha'on U; Thanan R; Sithithaworn P; Miwa M; Yongvanit P
Parasitol Int; 2012 Mar; 61(1):140-4. PubMed ID: 21763456
[TBL] [Abstract][Full Text] [Related]
26. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
Buisson Y
Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
[TBL] [Abstract][Full Text] [Related]
27. The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer.
Sripa B; Brindley PJ; Mulvenna J; Laha T; Smout MJ; Mairiang E; Bethony JM; Loukas A
Trends Parasitol; 2012 Oct; 28(10):395-407. PubMed ID: 22947297
[TBL] [Abstract][Full Text] [Related]
28. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
Wangboon C; Yongvanit P; Loilome W; Thanan R; Worasith C; Eamudomkarn C; Chamadol N; Mairiang E; Sithithaworn J; Saichua P; Sripa B; Khuntikeo N; Bethony JM; Sithithaworn P
Am J Trop Med Hyg; 2018 Jun; 98(6):1763-1769. PubMed ID: 29637887
[TBL] [Abstract][Full Text] [Related]
29. Recent Advances in the Diagnosis and Detection of Opisthorchis viverrini Sensu Lato in Human and Intermediate Hosts for Use in Control and Elimination Programs.
Saijuntha W; Duenngai K; Tangkawattana S; Petney TN; Andrews RH; Sithithaworn P
Adv Parasitol; 2018; 101():177-214. PubMed ID: 29907254
[TBL] [Abstract][Full Text] [Related]
30. Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection.
Pinlaor S; Prakobwong S; Boonmars T; Wongkham C; Pinlaor P; Hiraku Y
Acta Trop; 2009 Aug; 111(2):181-91. PubMed ID: 19427296
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory and anti-periductal fibrosis effects of an anthocyanin complex in Opisthorchis viverrini-infected hamsters.
Intuyod K; Priprem A; Limphirat W; Charoensuk L; Pinlaor P; Pairojkul C; Lertrat K; Pinlaor S
Food Chem Toxicol; 2014 Dec; 74():206-15. PubMed ID: 25447758
[TBL] [Abstract][Full Text] [Related]
32. Bile canalicular changes and defective bile secretion in Opisthorchis viverrini-infected hamsters.
Charoensuk L; Pinlaor P; Laothong U; Yongvanit P; Pairojkul C; Nawa Y; Pinlaor S
Folia Parasitol (Praha); 2014 Dec; 61(6):512-22. PubMed ID: 25651692
[TBL] [Abstract][Full Text] [Related]
33. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
Yongvanit P; Pinlaor S; Loilome W
J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
[TBL] [Abstract][Full Text] [Related]
34. Opisthorchis viverrini infection causes liver and biliary cirrhosis in gerbils.
Wonkchalee O; Boonmars T; Kaewkes S; Chamgramol Y; Pairojkul C; Wu Z; Juasook A; Sudsarn P; Boonjaraspinyo S
Parasitol Res; 2011 Sep; 109(3):545-51. PubMed ID: 21340565
[TBL] [Abstract][Full Text] [Related]
35. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma.
Akai PS; Pungpak S; Chaicumpa W; Viroj K; Bunnag D; Befus AD
Trans R Soc Trop Med Hyg; 1994; 88(4):471-4. PubMed ID: 7570848
[TBL] [Abstract][Full Text] [Related]
36. MRI and (1)H MRS evaluation for the serial bile duct changes in hamsters after infection with Opisthorchis viverrini.
Hanpanich P; Pinlaor S; Charoensuk L; Yongvanit P; Thomas C; Kothan S; Mairiang E
Magn Reson Imaging; 2013 Oct; 31(8):1418-25. PubMed ID: 23891436
[TBL] [Abstract][Full Text] [Related]
37. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
Sudsarn P; Boonmars T; Ruangjirachuporn W; Namwat N; Loilome W; Sriraj P; Aukkanimart R; Nadchanan W; Jiraporn S
Pathol Oncol Res; 2016 Jan; 22(1):57-65. PubMed ID: 26277607
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasis.
Sawangsoda P; Sithithaworn J; Tesana S; Pinlaor S; Boonmars T; Mairiang E; Yongvanit P; Duenngai K; Sithithaworn P
Parasitol Int; 2012 Mar; 61(1):196-202. PubMed ID: 21704727
[TBL] [Abstract][Full Text] [Related]
39. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter.
Deenonpoe R; Chomvarin C; Pairojkul C; Chamgramol Y; Loukas A; Brindley PJ; Sripa B
Asian Pac J Cancer Prev; 2015; 16(5):1751-8. PubMed ID: 25773821
[TBL] [Abstract][Full Text] [Related]
40. Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters.
Charoensuk L; Pinlaor P; Wanichwecharungruang S; Intuyod K; Vaeteewoottacharn K; Chaidee A; Yongvanit P; Pairojkul C; Suwannateep N; Pinlaor S
Nanomedicine; 2016 Jan; 12(1):21-32. PubMed ID: 26542278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
